We are live on ! Find out more
BIOA

BioAmber Inc.
BIOA

Delisted

BIOA was delisted on the 8th of February, 2018.

30 hedge funds and large institutions have $7.67M invested in BioAmber Inc. in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

23% less funds holding

Funds holding: 3930 (-9)

69% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 13

85% less capital invested

Capital invested by funds: $50.2M → $7.67M (-$42.5M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
30
Holders Change
-9
Holders Change %
-23.08%
% of All Funds
0.75%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
4
Increased
9
Reduced
7
Closed
13
Calls
Puts
Net Calls
Net Calls Change

BIOA Hedge Fund Activity: Q3 2017 in Review

30 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q3 2017, worth a combined $7.67M — down 85% from $50.2M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of BIOA and 4 opened new positions — a net loss of 9 holders — while 7 trimmed existing stakes and 9 added.

The largest buyer was NN Investment Partners Holdings, adding an estimated $6.36M. The largest seller was Waddell & Reed Financial, exiting entirely with an estimated $19.1M sold.

  • 30 institutional investors held BioAmber Inc. (BIOA) as of Q3 2017, down from 39 in Q2 2017.
  • Funds reported $7.67M of BioAmber Inc. stock for Q3 2017, down 85% quarter-over-quarter.
  • 4 funds opened new BioAmber Inc. positions in Q3 2017 and 13 closed out, a net change of -9 holders.
  • The largest BioAmber Inc. buyer in Q3 2017 was NN Investment Partners Holdings, an estimated $6.36M added.
  • The largest BioAmber Inc. seller in Q3 2017 was Waddell & Reed Financial, an estimated $19.1M sold.

Based on aggregated 13F filings for Q3 2017.